SG11202106249QA - Methods for improved immunotherapy - Google Patents
Methods for improved immunotherapyInfo
- Publication number
- SG11202106249QA SG11202106249QA SG11202106249QA SG11202106249QA SG11202106249QA SG 11202106249Q A SG11202106249Q A SG 11202106249QA SG 11202106249Q A SG11202106249Q A SG 11202106249QA SG 11202106249Q A SG11202106249Q A SG 11202106249QA SG 11202106249Q A SG11202106249Q A SG 11202106249QA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- improved immunotherapy
- immunotherapy
- improved
- Prior art date
Links
- 238000009169 immunotherapy Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/53—Liver
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Zoology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862621805P | 2018-01-25 | 2018-01-25 | |
| PCT/IL2019/050104 WO2019145956A1 (en) | 2018-01-25 | 2019-01-24 | Methods for improved immunotherapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202106249QA true SG11202106249QA (en) | 2021-07-29 |
Family
ID=65729410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202106249QA SG11202106249QA (en) | 2018-01-25 | 2019-01-24 | Methods for improved immunotherapy |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220072042A1 (he) |
| EP (1) | EP3914267A1 (he) |
| JP (1) | JP2022513330A (he) |
| KR (1) | KR20210126556A (he) |
| CN (1) | CN113597312A (he) |
| AU (1) | AU2019211777A1 (he) |
| BR (1) | BR112021014546A2 (he) |
| CA (1) | CA3127176A1 (he) |
| IL (1) | IL284816A (he) |
| SG (1) | SG11202106249QA (he) |
| WO (1) | WO2019145956A1 (he) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116617222B (zh) * | 2023-05-10 | 2024-05-03 | 徐州医科大学 | 小分子离子通道阻滞剂mk-801在制备治疗肿瘤或抗感染药物的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| WO2006111967A2 (en) * | 2005-04-18 | 2006-10-26 | Mia Levite | Method for augmenting the ability of t-cells and other cells for fighting disease and invade diseased organs, for elevating cd3 zeta and tnf-alpha expression in t-cells, and mixing t-cell boosting devices and kit particularly useful in such method |
| EP1917275A4 (en) * | 2005-08-03 | 2009-01-28 | Mineuet Therapeutics Ltd | MODULATION OF THE VOLTAGE-RELATED KV1.1 CALIUM CHANNEL OF T-CELLS FOR REGULATING SYNTHESIS AND DEGRADATION OF THE TUMOR NECROSIS FACTOR (TNF) AND FOR TREATING HUMAN DISEASES CAUSED BY HARMFULLY HIGH OR LOW TNF MIRRORS |
| WO2007019267A1 (en) * | 2005-08-03 | 2007-02-15 | Mineuet Therapeutics Ltd. | MODULATING THE KV1.1 VOLTAGE-GATED POTASSIUM CHANNEL IN T-CELLS FOR REGULATING THE SYNTHESIS AND SECRETION OF TUMOR NECROSIS FACTOR α (TNF-α) AND TREATING HUMAN DISEASES OR INJURIES MEDIATED BY DETRIMENTALLY HIGH OR LOW LEVELS OF TNF-α |
| US20140065096A1 (en) * | 2012-09-05 | 2014-03-06 | Regen BioPharma, Inc. | Cancer therapy by ex vivo activated autologous immune cells |
| EP4101461A1 (en) * | 2014-01-09 | 2022-12-14 | Hadasit Medical Research Services and Development Ltd. | Improved cell compositions and methods for cancer therapy |
| CA2992551A1 (en) * | 2015-07-21 | 2017-01-26 | Novartis Ag | Methods for improving the efficacy and expansion of immune cells |
| JP7084304B2 (ja) * | 2015-10-28 | 2022-06-14 | ライフ テクノロジーズ エーエス | 細胞表面シグナル及びシグナル比を変えることによる、異なるｔ細胞亜集団の選択的増殖の方法 |
-
2019
- 2019-01-24 WO PCT/IL2019/050104 patent/WO2019145956A1/en active Application Filing
- 2019-01-24 EP EP19710502.6A patent/EP3914267A1/en active Pending
- 2019-01-24 SG SG11202106249QA patent/SG11202106249QA/en unknown
- 2019-01-24 AU AU2019211777A patent/AU2019211777A1/en not_active Abandoned
- 2019-01-24 US US17/424,499 patent/US20220072042A1/en active Pending
- 2019-01-24 BR BR112021014546-0A patent/BR112021014546A2/pt unknown
- 2019-01-24 JP JP2021543486A patent/JP2022513330A/ja active Pending
- 2019-01-24 CA CA3127176A patent/CA3127176A1/en active Pending
- 2019-01-24 KR KR1020217022540A patent/KR20210126556A/ko not_active Application Discontinuation
- 2019-01-24 CN CN201980091985.4A patent/CN113597312A/zh active Pending
-
2021
- 2021-07-13 IL IL284816A patent/IL284816A/he unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN113597312A (zh) | 2021-11-02 |
| AU2019211777A1 (en) | 2021-09-16 |
| EP3914267A1 (en) | 2021-12-01 |
| JP2022513330A (ja) | 2022-02-07 |
| CA3127176A1 (en) | 2019-08-01 |
| IL284816A (he) | 2021-08-31 |
| US20220072042A1 (en) | 2022-03-10 |
| BR112021014546A2 (pt) | 2021-10-05 |
| KR20210126556A (ko) | 2021-10-20 |
| WO2019145956A1 (en) | 2019-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL282225A (he) | תכשירים ושיטות לאימונותרפיה | |
| IL259793A (he) | פפטידים slc45a2 עבור טיפול חיסוני | |
| IL280913A (he) | שיטות חדשות | |
| IL283331A (he) | שיטה להכנת n-פנילפיראזול-1-קרבוקסאמידים | |
| IL280912A (he) | שיטות חדשות | |
| IL283644A (he) | תכשירים ושיטות לאימונותרפיה | |
| IL289589A (he) | שיטות חדשות | |
| GB201803724D0 (en) | Methods | |
| GB201903229D0 (en) | Immunotherapy | |
| GB201907882D0 (en) | Methods | |
| GB201802486D0 (en) | Methods | |
| GB201913716D0 (en) | Methods | |
| SG11202007342QA (en) | Methods | |
| GB201906705D0 (en) | Methods | |
| GB201820751D0 (en) | Methods for preparing intermediates | |
| GB201820754D0 (en) | Methods for preparing compounds | |
| IL284816A (he) | שיטות אימונותרפיה משופרות | |
| GB201805466D0 (en) | Methods | |
| IL291343A (he) | תרכובות ושיטות לאימונותרפיה | |
| IL265103B2 (he) | טיפול חיסוני לפוליאומוירוסים | |
| IL282108A (he) | שיטה להכנת אפיקונזול | |
| IL268489B2 (he) | אבוב | |
| GB201907157D0 (en) | Methods | |
| GB201903909D0 (en) | Methods | |
| GB201814451D0 (en) | Methods |